Beta testing, talks and potential do not = $$$. No significant sales - that we know of, outside of paid beta testing, have occurred. How long can CurAegis survive without an infusion of cash that will undoubtedly further dilute our shares? Kaplan, TG and the other big stakeholders may save the day but I'm afraid common shareholders will pay a big price for any rescue.